ReviewDrug safety2006

Pharmacovigilance during the pre-approval phases: an evolving pharmaceutical industry model in response to ICH E2E, CIOMS VI, FDA and EMEA/CHMP risk-management guidelines.

Craig G Hartford et al.PubMed ↗Publisher ↗

No numbers read from the abstract.